Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease

<p><strong>Background:&nbsp;</strong>It is important to identify molecular features that improve prostate cancer (PCa) risk stratification before radical treatment with curative intent. Molecular analysis of historical diagnostic formalin-fixed paraffin-embedded (FFPE) prostate...

詳細記述

書誌詳細
主要な著者: Charlton, PV, O'Reilly, D, Philippou, Y, Rao, SR, Lamb, ADG, Mills, IG, Higgins, GS, Hamdy, FC, Verrill, C, Buffa, FM, Bryant, RJ
フォーマット: Journal article
言語:English
出版事項: Wiley 2024
_version_ 1826313265130504192
author Charlton, PV
O'Reilly, D
Philippou, Y
Rao, SR
Lamb, ADG
Mills, IG
Higgins, GS
Hamdy, FC
Verrill, C
Buffa, FM
Bryant, RJ
author_facet Charlton, PV
O'Reilly, D
Philippou, Y
Rao, SR
Lamb, ADG
Mills, IG
Higgins, GS
Hamdy, FC
Verrill, C
Buffa, FM
Bryant, RJ
author_sort Charlton, PV
collection OXFORD
description <p><strong>Background:&nbsp;</strong>It is important to identify molecular features that improve prostate cancer (PCa) risk stratification before radical treatment with curative intent. Molecular analysis of historical diagnostic formalin-fixed paraffin-embedded (FFPE) prostate biopsies from cohorts with post-radiotherapy (RT) long-term clinical follow-up has been limited. Utilizing parallel sequencing modalities, we performed a proof-of-principle sequencing analysis of historical diagnostic FFPE prostate biopsies. We compared patients with (i) stable PCa (sPCa)&nbsp;postprimary or salvage RT,&nbsp;(ii) progressing PCa (pPCa) post-RT,&nbsp;and (iii) de novo metastatic PCa&nbsp;(mPCa).</p> <p><strong>Methods:&nbsp;</strong>A cohort of 19 patients with diagnostic prostate biopsies (<em>n</em>&thinsp;=&thinsp;6 sPCa,&nbsp;<em>n</em>&thinsp;=&thinsp;5 pPCa,&nbsp;<em>n</em>&thinsp;=&thinsp;8 mPCa) and mean 4 years 10 months follow-up (diagnosed 2009&ndash;2016) underwent nucleic acid extraction from demarcated malignancy. Samples underwent 3&prime;RNA sequencing (3&prime;RNAseq) (<em>n</em>&thinsp;=&thinsp;19), nanoString analysis (<em>n</em>&thinsp;=&thinsp;12), and Illumina 850k methylation (<em>n</em>&thinsp;=&thinsp;8) sequencing. Bioinformatic analysis was performed to coherently identify differentially expressed genes and methylated genomic regions (MGRs).</p> <p><strong>Results:&nbsp;</strong>Eighteen of 19 samples provided useable 3&prime;RNAseq data. Principal component analysis (PCA) demonstrated similar expression profiles between pPCa and mPCa cases, versus sPCa. Coherently differentially methylated probes between these groups identified ~600 differentially MGRs. The top 50 genes with increased expression in pPCa patients were associated with reduced progression-free survival post-RT (<em>p</em>&thinsp;&lt;&thinsp;0.0001) in an external cohort.</p> <p><strong>Conclusions:&nbsp;</strong>3&prime;RNAseq, nanoString and 850k-methylation analyses are each achievable from historical FFPE diagnostic pretreatment prostate biopsies, unlocking the potential to utilize large cohorts of historic clinical samples. Profiling similarities between individuals with pPCa and mPCa suggests biological similarities and historical radiological staging limitations, which warrant further investigation.</p>
first_indexed 2024-09-25T04:10:21Z
format Journal article
id oxford-uuid:51a8b9ce-a8ad-4813-a257-e2e26e006e2b
institution University of Oxford
language English
last_indexed 2024-09-25T04:10:21Z
publishDate 2024
publisher Wiley
record_format dspace
spelling oxford-uuid:51a8b9ce-a8ad-4813-a257-e2e26e006e2b2024-06-21T15:59:24ZMolecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic diseaseJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:51a8b9ce-a8ad-4813-a257-e2e26e006e2bEnglishSymplectic ElementsWiley2024Charlton, PVO'Reilly, DPhilippou, YRao, SRLamb, ADGMills, IGHiggins, GSHamdy, FCVerrill, CBuffa, FMBryant, RJ<p><strong>Background:&nbsp;</strong>It is important to identify molecular features that improve prostate cancer (PCa) risk stratification before radical treatment with curative intent. Molecular analysis of historical diagnostic formalin-fixed paraffin-embedded (FFPE) prostate biopsies from cohorts with post-radiotherapy (RT) long-term clinical follow-up has been limited. Utilizing parallel sequencing modalities, we performed a proof-of-principle sequencing analysis of historical diagnostic FFPE prostate biopsies. We compared patients with (i) stable PCa (sPCa)&nbsp;postprimary or salvage RT,&nbsp;(ii) progressing PCa (pPCa) post-RT,&nbsp;and (iii) de novo metastatic PCa&nbsp;(mPCa).</p> <p><strong>Methods:&nbsp;</strong>A cohort of 19 patients with diagnostic prostate biopsies (<em>n</em>&thinsp;=&thinsp;6 sPCa,&nbsp;<em>n</em>&thinsp;=&thinsp;5 pPCa,&nbsp;<em>n</em>&thinsp;=&thinsp;8 mPCa) and mean 4 years 10 months follow-up (diagnosed 2009&ndash;2016) underwent nucleic acid extraction from demarcated malignancy. Samples underwent 3&prime;RNA sequencing (3&prime;RNAseq) (<em>n</em>&thinsp;=&thinsp;19), nanoString analysis (<em>n</em>&thinsp;=&thinsp;12), and Illumina 850k methylation (<em>n</em>&thinsp;=&thinsp;8) sequencing. Bioinformatic analysis was performed to coherently identify differentially expressed genes and methylated genomic regions (MGRs).</p> <p><strong>Results:&nbsp;</strong>Eighteen of 19 samples provided useable 3&prime;RNAseq data. Principal component analysis (PCA) demonstrated similar expression profiles between pPCa and mPCa cases, versus sPCa. Coherently differentially methylated probes between these groups identified ~600 differentially MGRs. The top 50 genes with increased expression in pPCa patients were associated with reduced progression-free survival post-RT (<em>p</em>&thinsp;&lt;&thinsp;0.0001) in an external cohort.</p> <p><strong>Conclusions:&nbsp;</strong>3&prime;RNAseq, nanoString and 850k-methylation analyses are each achievable from historical FFPE diagnostic pretreatment prostate biopsies, unlocking the potential to utilize large cohorts of historic clinical samples. Profiling similarities between individuals with pPCa and mPCa suggests biological similarities and historical radiological staging limitations, which warrant further investigation.</p>
spellingShingle Charlton, PV
O'Reilly, D
Philippou, Y
Rao, SR
Lamb, ADG
Mills, IG
Higgins, GS
Hamdy, FC
Verrill, C
Buffa, FM
Bryant, RJ
Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease
title Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease
title_full Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease
title_fullStr Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease
title_full_unstemmed Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease
title_short Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease
title_sort molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post radiotherapy and those with de novo metastatic disease
work_keys_str_mv AT charltonpv molecularanalysisofarchivaldiagnosticprostatecancerbiopsiesidentifiesgenomicsimilaritiesincaseswithprogressionpostradiotherapyandthosewithdenovometastaticdisease
AT oreillyd molecularanalysisofarchivaldiagnosticprostatecancerbiopsiesidentifiesgenomicsimilaritiesincaseswithprogressionpostradiotherapyandthosewithdenovometastaticdisease
AT philippouy molecularanalysisofarchivaldiagnosticprostatecancerbiopsiesidentifiesgenomicsimilaritiesincaseswithprogressionpostradiotherapyandthosewithdenovometastaticdisease
AT raosr molecularanalysisofarchivaldiagnosticprostatecancerbiopsiesidentifiesgenomicsimilaritiesincaseswithprogressionpostradiotherapyandthosewithdenovometastaticdisease
AT lambadg molecularanalysisofarchivaldiagnosticprostatecancerbiopsiesidentifiesgenomicsimilaritiesincaseswithprogressionpostradiotherapyandthosewithdenovometastaticdisease
AT millsig molecularanalysisofarchivaldiagnosticprostatecancerbiopsiesidentifiesgenomicsimilaritiesincaseswithprogressionpostradiotherapyandthosewithdenovometastaticdisease
AT higginsgs molecularanalysisofarchivaldiagnosticprostatecancerbiopsiesidentifiesgenomicsimilaritiesincaseswithprogressionpostradiotherapyandthosewithdenovometastaticdisease
AT hamdyfc molecularanalysisofarchivaldiagnosticprostatecancerbiopsiesidentifiesgenomicsimilaritiesincaseswithprogressionpostradiotherapyandthosewithdenovometastaticdisease
AT verrillc molecularanalysisofarchivaldiagnosticprostatecancerbiopsiesidentifiesgenomicsimilaritiesincaseswithprogressionpostradiotherapyandthosewithdenovometastaticdisease
AT buffafm molecularanalysisofarchivaldiagnosticprostatecancerbiopsiesidentifiesgenomicsimilaritiesincaseswithprogressionpostradiotherapyandthosewithdenovometastaticdisease
AT bryantrj molecularanalysisofarchivaldiagnosticprostatecancerbiopsiesidentifiesgenomicsimilaritiesincaseswithprogressionpostradiotherapyandthosewithdenovometastaticdisease